Results 91 to 100 of about 1,122,324 (312)

Blood component therapy in patients having massive obstetric hemorrhage in a tertiary care center in Puducherry. [PDF]

Asian J Transfus Sci, 2023
Anuragaa S, Chaturvedula L, Basavarajegowda A.   +2 more
europepmc   +1 more source

Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised [PDF]

, 2016

openalex   +1 more source

Transfusion of Modified Blood Components for the Treatment of Autoimmune Hemolytic Anemia: A Network Meta-Analysis

, 2021
Jiawen Deng, Fangwen Zhou, Chi Yi Wong, Elena Zheng, Emma Huang   +4 more
openalex   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

Molecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath, Irene A. George, Srikanth S. Manda, Prasanth Ariyannur, Ekta R. Dhawale, Raja Sekhar Kommu, Rajan Datar, Darshana Patil, Vinita Trivedi, Manisha Singh, Kumar Prabhash, Sewanti Limaye, Richa Chauhan, Prashant Kumar   +13 more
wiley   +1 more source

The present situation and advance of red blood cell transfusion triggers

Zhongguo shuxue zazhi
In clinical practice, red blood cell infusion needs to be based on the patient′s hemoglobin level. However, different guidelines recommend different thresholds for red blood cell infusion and the timing of blood transfusion initiation is still ...
Yuye CHEN, Hong LYU, Qian LI, Jingjia SHEN, Jia SHI   +4 more
doaj   +1 more source

Towards an Innovative Sensor in Smart Capsule for Aerial Drones for Blood and Blood Component Delivery. [PDF]

Micromachines (Basel), 2022
Liu R, Pitruzzello G, Rosa M, Battisti A, Cerri C, Tortora G.   +5 more
europepmc   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Plasma Fibrinogen as a Predictor of Perioperative-Blood-Component Transfusion in Major-Nontraumatic-Orthopedic-Surgery Patients: A Cohort Study. [PDF]

Diagnostics (Basel), 2023
Pagnussatt Neto E, Lopes da Costa PD, Gurgel SJT, Schmidt Azevedo P, Modolo NSP, do Nascimento Junior P.   +5 more
europepmc   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Retrospective Analysis of Reasons for Discarding Whole Blood and Blood Components at Tertiary Care Hospital Blood Bank in South Gujarat

National Journal of Community Medicine, 2017
Introduction: Blood transfusion is an integral part of medical practice. Proper utilization of blood and its components with minimal wastage is necessary because each unit of blood is precious.
Niketa Roy, Ankita Shah
doaj